Sanofi pulls cough mixtures after phenol detected
Drug major Sanofi Aventis has recalled three of its cough syrup mixtures in France after traces of phenol were found in the products.
Archives for July 12, 2009
Roche begins cutting jobs at Genentech
Swiss firm Roche has begun making cuts at recent $46.8bn biotech acquisition Genentech, in the first stage of a widely anticipated integration programme.
Icon buys Veeda’s UK biomarker lab
The Oxford, UK, biomarker laboratory facilities of India’s Veeda CR have been taken over by Icon Development Solutions, in a deal which both consolidates existing customer relationships for the buyer and opens up new product areas to focus on.
Mallinckrodt pulls “subpotent” Cr-51 batch
Mallinckrodt Pharmaceuticals has recalled one batch of its sodium chromate Cr-51 diagnostic agent after FDA post-marketing tests revealed that some of the products were “subpotent.”
“Velos on-demand” launched to help CROs cut spending
US software company Velos hopes its new “software as a service” (SaaS) internet offering will attract CROs and Pharma firms seeking low-cost trial management solutions.
Ranbaxy pulls batch of acne drug in US
Indian generics firm Ranbaxy voluntarily withdrew one batch of its acne drug isotretinoin from US shelves late last week after FDA analysis revealed out of spec dissolution test results.
CRO gets NCI grant to boost cancer trial recruitment
The US National Cancer Institute (NCI) will provide specialist trial group Cancer Research for the Ozarks (CRO) with a $4.2m grant to support its clinical programme.